Analyst picks & changes

Amgen Inc.

(AMGN)

Oppenheimer & Co. analyst Matthew Geller raised Amgen Inc. to a "buy" from "market performer," prior to Friday's announcement of the deal with Synergen Inc. He said that if

Read the full 327 word article

How to gain access

Continue reading with a
two-week free trial.